Screener
ImmunityBio, Inc. IBRX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from ImmunityBio, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
FAQ
- What is ImmunityBio, Inc.'s price / sales?
- ImmunityBio, Inc. (IBRX) reported price / sales of 56.2× in Q1 2026.
- How has ImmunityBio, Inc.'s price / sales changed year-over-year?
- ImmunityBio, Inc.'s price / sales decreased by 31.7% year-over-year, from 82.3× to 56.2×.
- What is the long-term trend for ImmunityBio, Inc.'s price / sales?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s price / sales has grown at a -69.6% compound annual growth rate (CAGR), from 6,600.2× to 17.2×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about ImmunityBio, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude